368 related articles for article (PubMed ID: 22348195)
1. Experience in international clinical research: the HIV Prevention Trials Network.
Sista ND; Abdool Karim Q; Hinson K; Donnell D; Eshleman SH; Vermund SH
Clin Investig (Lond); 2011 Dec; 1(12):1609-1618. PubMed ID: 22348195
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Can combination prevention strategies reduce HIV transmission in generalized epidemic settings in Africa? The HPTN 071 (PopART) study plan in South Africa and Zambia.
Vermund SH; Fidler SJ; Ayles H; Beyers N; Hayes RJ
J Acquir Immune Defic Syndr; 2013 Jul; 63 Suppl 2(0 2):S221-7. PubMed ID: 23764639
[TBL] [Abstract][Full Text] [Related]
4. Reaping the prevention benefits of highly active antiretroviral treatment: policy implications of HIV Prevention Trials Network 052.
Forsyth AD; Valdiserri RO
Curr Opin HIV AIDS; 2012 Mar; 7(2):111-6. PubMed ID: 22227586
[TBL] [Abstract][Full Text] [Related]
5. Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.
Johnson WD; Diaz RM; Flanders WD; Goodman M; Hill AN; Holtgrave D; Malow R; McClellan WM
Cochrane Database Syst Rev; 2008 Jul; (3):CD001230. PubMed ID: 18646068
[TBL] [Abstract][Full Text] [Related]
6. Prevention of HIV Transmission and the HPTN 052 Study.
Cohen MS; Gamble T; McCauley M
Annu Rev Med; 2020 Jan; 71():347-360. PubMed ID: 31652410
[TBL] [Abstract][Full Text] [Related]
7. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
8. Design of the HPTN 065 (TLC-Plus) study: A study to evaluate the feasibility of an enhanced test, link-to-care, plus treat approach for HIV prevention in the United States.
Gamble T; Branson B; Donnell D; Hall HI; King G; Cutler B; Hader S; Burns D; Leider J; Wood AF; G Volpp K; Buchacz K; El-Sadr WM;
Clin Trials; 2017 Aug; 14(4):322-332. PubMed ID: 28627929
[TBL] [Abstract][Full Text] [Related]
9. Pre-exposure prophylaxis initiation and adherence among Black men who have sex with men (MSM) in three US cities: results from the HPTN 073 study.
Wheeler DP; Fields SD; Beauchamp G; Chen YQ; Emel LM; Hightow-Weidman L; Hucks-Ortiz C; Kuo I; Lucas J; Magnus M; Mayer KH; Nelson LE; Hendrix CW; Piwowar-Manning E; Shoptaw S; Watkins P; Watson CC; Wilton L
J Int AIDS Soc; 2019 Feb; 22(2):e25223. PubMed ID: 30768776
[TBL] [Abstract][Full Text] [Related]
10. Regional differences between people who inject drugs in an HIV prevention trial integrating treatment and prevention (HPTN 074): a baseline analysis.
Lancaster KE; Hoffman IF; Hanscom B; Ha TV; Dumchev K; Susami H; Rose S; Go VF; Reifeis SA; Mollan KR; Hudgens MG; Piwowar-Manning EM; Richardson P; Dvoriak S; Djoerban Z; Kiriazova T; Zeziulin O; Djauzi S; Ahn CV; Latkin C; Metzger D; Burns DN; Sugarman J; Strathdee SA; Eshleman SH; Clarke W; Donnell D; Emel L; Sunner LE; McKinstry L; Sista N; Hamilton EL; Lucas JP; Duong BD; Van Vuong N; Sarasvita R; Miller WC;
J Int AIDS Soc; 2018 Oct; 21(10):e25195. PubMed ID: 30350406
[TBL] [Abstract][Full Text] [Related]
11. Establishing HIV treatment as prevention in the HIV Prevention Trials Network 052 randomized trial: an ethical odyssey.
Cohen MS; McCauley M; Sugarman J
Clin Trials; 2012 Jun; 9(3):340-7. PubMed ID: 22692805
[TBL] [Abstract][Full Text] [Related]
12. Causes and risk factors of death among people who inject drugs in Indonesia, Ukraine and Vietnam: findings from HPTN 074 randomized trial.
Dumchev K; Guo X; Ha TV; Djoerban Z; Zeziulin O; Go VF; Sarasvita R; Metzger DS; Latkin CA; Rose SM; Piwowar-Manning E; Richardson P; Hanscom B; Lancaster KE; Miller WC; Hoffman IF
BMC Infect Dis; 2023 May; 23(1):319. PubMed ID: 37170118
[TBL] [Abstract][Full Text] [Related]
13. Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count.
Bigna JJ; Plottel CS; Koulla-Shiro S
Infect Dis Poverty; 2016 Sep; 5(1):85. PubMed ID: 27593965
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral Therapy to Prevent HIV Acquisition in Serodiscordant Couples in a Hyperendemic Community in Rural South Africa.
Oldenburg CE; Bärnighausen T; Tanser F; Iwuji CC; De Gruttola V; Seage GR; Mimiaga MJ; Mayer KH; Pillay D; Harling G
Clin Infect Dis; 2016 Aug; 63(4):548-54. PubMed ID: 27208044
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial.
Marzinke MA; Hanscom B; Wang Z; Safren SA; Psaros C; Donnell D; Richardson PA; Sullivan P; Eshleman SH; Jennings A; Feliciano KG; Jalil E; Coutinho C; Cardozo N; Maia B; Khan T; Singh Y; Middelkoop K; Franks J; Valencia J; Sanchez N; Lucas J; Rooney JF; Rinehart AR; Ford S; Adeyeye A; Cohen MS; McCauley M; Landovitz RJ; Grinsztejn B;
Lancet HIV; 2023 Nov; 10(11):e703-e712. PubMed ID: 37783219
[TBL] [Abstract][Full Text] [Related]
16. Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study.
Hallett TB; Baeten JM; Heffron R; Barnabas R; de Bruyn G; Cremin Í; Delany S; Garnett GP; Gray G; Johnson L; McIntyre J; Rees H; Celum C
PLoS Med; 2011 Nov; 8(11):e1001123. PubMed ID: 22110407
[TBL] [Abstract][Full Text] [Related]
17. Tuberculosis prevalence after 4 years of population-wide systematic TB symptom screening and universal testing and treatment for HIV in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: A cross-sectional survey (TREATS).
Klinkenberg E; Floyd S; Shanaube K; Mureithi L; Gachie T; de Haas P; Kosloff B; Dodd PJ; Ruperez M; Wapamesa C; Burnett JM; Kalisvaart N; Kasese N; Vermaak R; Schaap A; Fidler S; Hayes R; Ayles H;
PLoS Med; 2023 Sep; 20(9):e1004278. PubMed ID: 37682971
[TBL] [Abstract][Full Text] [Related]
18. Impact of universal testing and treatment on sexual risk behaviour and herpes simplex virus type 2: a prespecified secondary outcomes analysis of the HPTN 071 (PopART) community-randomised trial.
Wilson E; Donnell D; Skalland T; Floyd S; Moore A; Bell-Mandla N; Bwalya J; Kasese N; Dunbar R; Shanaube K; Kosloff B; Laeyendecker O; Agyei Y; Hoddinott G; Bock P; Fidler S; Hayes R; Ayles H;
Lancet HIV; 2022 Nov; 9(11):e760-e770. PubMed ID: 36332653
[TBL] [Abstract][Full Text] [Related]
19. Assessing risk for HIV infection among adolescent girls in South Africa: an evaluation of the VOICE risk score (HPTN 068).
Giovenco D; Pettifor A; MacPhail C; Kahn K; Wagner R; Piwowar-Manning E; Wang J; Hughes JP
J Int AIDS Soc; 2019 Jul; 22(7):e25359. PubMed ID: 31353814
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
